| Income Statement |
| Total Revenue | 141.25M |
|
| Revenues (USD) | 141.25M |
| Cost of Revenue | 31.94M |
| Gross Profit | 109.31M |
| Operating Expenses | 108.79M |
| Research and Development Expense | 24.24M |
| Selling, General and Administrative Expense | 84.55M |
| Operating Income | 526.00K |
| Interest Expense | 1.34M |
| Income Tax Expense | 286.00K |
| Net Income | 108.00K |
| Net Income Common Stock | 108.00K |
| Net Income Common Stock (USD) | 108.00K |
| Consolidated Income | 108.00K |
| Earning Before Interest & Taxes (EBIT) | 1.73M |
| Earning Before Interest & Taxes (USD) | 1.73M |
| Weighted Average Shares | 48.33M |
| Weighted Average Shares Diluted | 49.05M |
| Balance Sheet |
| Cash and Equivalents | 146.17M |
| Cash and Equivalents (USD) | 146.17M |
| Trade and Non-Trade Receivables | 71.31M |
| Current Assets | 313.69M |
| Property, Plant & Equipment Net | 46.19M |
| Total Assets | 643.99M |
| Total Debt | 71.78M |
| Current Liabilities | 73.19M |
| Debt Non-Current | 71.78M |
| Total Liabilities | 152.29M |
| Accumulated Retained Earnings (Deficit) | -413.09M |
| Accumulated Other Comprehensive Income | 227.00K |
| Shareholders Equity | 491.69M |
| Shareholders Equity (USD) | 491.69M |
| Assets Non-Current | 330.30M |
| Total Debt (USD) | 71.78M |
| Goodwill and Intangible Assets | 280.42M |
| Inventory | 81.14M |
| Liabilities Non-Current | 79.10M |
| Trade and Non-Trade Payables | 30.56M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 5.27M |
| Net Cash Flow from Financing | -13.25M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.26M |
| Capital Expenditure | -3.85M |
| Issuance (Purchase) of Equity Shares | -11.28M |
| Issuance (Repayment) of Debt Securities | -1.97M |
| Net Cash Flow from Investing | -3.85M |
| Net Cash Flow from Operations | -4.00M |
| Effect of Exchange Rate Changes on Cash | -160.00K |
| Share Based Compensation | 11.27M |